Date of purchase: 27/01/2025
Number of ordinary shares purchased: 470,000
Volume weighted average price paid per ordinary share (GBp): 50.3118
11:39:52-16:22:53 |
Date of purchase: 24/01/2025
Number of ordinary shares purchased: 380,000
Volume weighted average price paid per ordinary share (GBp): 51.6617
08:32:49-16:16:08 |
Date of purchase: 23/01/2025
Number of ordinary shares purchased: 380,000
Volume weighted average price paid per ordinary share (GBp): 51.6310
08:17:43-16:14:06 |
This time of year I like to look back over the year to see trend since the April before.
April 2024 - today, fairly flat.
Find out if there is likely a tax loss selling downdraught but looking at the trend the past year I GUESS it's not a massive backlog ready to exit. They are already gone and buyback will mop-up too. |
Date of purchase: 22/01/2025
Number of ordinary shares purchased: 350,000
Volume weighted average price paid per ordinary share (GBp): 52.0564
08:07:48-16:20:28 |
Bit of volume showing up today. Also coincides with spike at ONT.
Hope this is more short covering.
IPO needs to keep the volume up if the buyback is to stay at current levels. |
Date of purchase: 21/01/2025
Number of ordinary shares purchased: 380,000
Volume weighted average price paid per ordinary share (GBp): 51.5215
08:22:56-16:18:31 |
Date of purchase: 20/01/2025
Number of ordinary shares purchased: 438,096
Volume weighted average price paid per ordinary share (GBp): 51.2761
08:30:24-16:16:51 |
 Oxa
Sunderland’s self-driving bus project announces Oxa as new autonomy provider
16 Jan 2025
The Sunderland Advanced Mobility Shuttle (SAMS) project is proud to announce Oxa as the new autonomy provider for its groundbreaking autonomous transport initiative, running during the first quarter of 2025.
Oxa will play a crucial role in bringing the project to life, delivering a state-of-the-art autonomous Ford E-Transit shuttle.
The initiative aims to illustrate how autonomous passenger shuttles can better connect people to key destinations within the city while reducing environmental impact. The project is a vital part of Sunderland’s ongoing smart city journey, using cutting-edge technology to create greener, more efficient transport solutions.
Councillor Michael Mordey, leader of Sunderland City Council, said: "The SAMS project marks a significant milestone in Sunderland’s smart city journey, and we are thrilled to welcome Oxa on board.
“This initiative is not just about testing new technology; it's about improving the quality of life for our residents by offering efficient, sustainable transport options. Oxa’s expertise in autonomous vehicle technology is integral to our shared vision of creating a forward-thinking, sustainable transport system for the people of Sunderland.”
Oxa is experienced in providing autonomous vehicle solutions across a range of sectors, including shared passenger transportation and industrial logistics. The company’s self-driving software platform and services enable businesses to benefit from autonomy today - enhancing safety, efficiency and sustainability.
Gavin Jackson, CEO at Oxa, said: “We’re proud to be part of the movement to radically modernise public transport in the UK. We’re taking an innovative approach to bringing autonomy to customers and communities today, and are excited to be getting started in Sunderland.
“The project will demonstrate the potential of autonomous vehicles to create safe, efficient and sustainable transport solutions. We look forward to working closely with the council and partners to make this vision a reality."
Barney Smith, founder and CEO at Perform Green, added: "The introduction of Oxa into the SAMS project strengthens our mission to make Sunderland, and the North East, a hub of smart, autonomous innovation.
“This collaboration enables us to test and deliver real-world solutions that could redefine urban mobility for the better the world over.
“As Sunderland continues to lead the way in smart city development, the SAMS initiative is set to provide valuable insights into how autonomous transport can enhance connectivity and sustainability in urban environments.”
Passenger feedback will be collected throughout the project, for research purposes.
The SAMS project is led by Sunderland City Council and a consortium of six other public and private partners, and backed by the Centre for Connected & Autonomous Vehicles (CCAV) and Innovate UK, supported by Zenzic. For more information on the project, please visit the Sunderland Our Smart City website. |
Further to the buyback, the past twenty days average volume starts to drop off considerably towards the end of next week. Given the current limits on the buyback the co. will soon start to hit it's maximum 25% of the prior 20 days average volume. [It's currently buying back about 17% of the maximum.].
I am not sure how this will affect the sp, or the shorts.
If management are reading this, it might be a good idea to ramp it up while you can!
[or consider increasing the current max percentage limit] |
As a rough guess, it looks to me as though management are currently pursuing a buyback at approx 1% of the company a month. |
Date of purchase: 17/01/2025
Number of ordinary shares purchased: 470,000
Volume weighted average price paid per ordinary share (GBp): 52.5913
08:22:09-16:34:13
Spread widened at 16:29:59 |
The IPO's share price curve follows closely the ONT share price in the last 5 years (I do not know how to add an image here), except during periods of intense buyback. Therefore, can we say that every successful sale did not affect the share price directly (as NAV increment), but indirectly, just as cash for buyback? |
Date of purchase: 16/01/2025
Number of ordinary shares purchased: 470,000
Volume weighted average price paid per ordinary share (GBp): 53.2589
09:26:07- 16:20:19 |
Date of purchase: 15/01/2025
Number of ordinary shares purchased: 151,757
Volume weighted average price paid per ordinary share (GBp): 51.8191
08:26:25-14:52:51 |
14/1/2025 TR-1 [edit, it was a Form 8.3] concerning Tissue Regenix [TRX]
Sold 2,071,017 shares [I think to Lexham] for cash income of £1,209,059.73
IP Group now hold 2,390,403 or 3.35% TRX |
Date of purchase: 14/01/2025
Number of ordinary shares purchased: 460,000
Volume weighted average price paid per ordinary share (GBp): 51.7553
08:17:45-16:19:42 |
Date of purchase: 13/01/2025
Number of ordinary shares purchased: 441,277
Volume weighted average price paid per ordinary share (GBp): 50.5606
08:23:10- 16:17:52 |
Value of ONT holding up around £25m this morning.
[Eod finished up about £10m] |
Jonesy, search Istesso or Leramistat in the 'search this thread' box in the header.
The Drug-Drug Interaction (DDI) Study of Leramistat appears to be ongoing. |
Does anyone have an insight on Istesso timings for clinical trial update. Seems to be dragging on and on. Is this usual. I read that it can take a long time but we are getting close to a year |
Market reacting positively to ONT update. |
Given the discount the buyback is a very sensible allocation of capital. Low risk (they have enough of that) and a boost to future EPS.
ONT TU reads well. |
Buybacks aren't in place to "fight the shorter". |
Bamboo, thank you for the detailed explanation
I am buying the dip and making some profit, but after all these successful news, I was hoping to do much more.
I am not a great fan of buyback, I do see it was important to fight the shorter, but I was wondering if cash could be more useful for investing and expanding the portfolio with different tech and biotech companies.
Or if nothing can be done, dividends would be good for me |
Register to chat with like-minded investors on our interactive forums.
Hot Features
Premium
